The number of cells in multicellular organism is tightly regulated. Not simply by controlling the rate of cell division, but also by controlling the rate of cell death. If cells are no longer needed, they commit suicide by activating an intracellular death program. This process is therefore called programmed cell death or apoptosis (from a Greek word meaning “falling off,” as leaves from a tree). The intrinsic apoptotic pathway occurs by the release of cytochrome c from mitochondria. The extrinsic apoptotic pathway is caused by the binding of death ligands, such as TNF (tumor necrosis factor), Fas, and TRAIL (TNF-related-apoptosis-inducing ligand), to their corresponding receptors. Although programmed cell death is involved in a number of key biological phenomena, aberrant apoptosis results in diverse human diseases [1]
The amount of apoptosis that occurs in developing and adult animal tissues is surprisingly large. In the developing vertebrate nervous system up to half or more of the nerve cells normally die soon after they are formed. In a healthy adult human, billions of cells die in the bone marrow and intestine every hour. Although this process seems remarkably wasteful -especially as the vast majority are perfectly healthy at the time they kill themselves- programmed cell death plays an important role during embryonic development, as hands and feet, for example, are sculpted by apoptosis: they start out as spadelike structures, and the individual digits separate only as the cells between them die. In other cases, cells die when the structure they form is no longer needed. When a tadpole changes into a frog, the cells in the tail die, and the tail, which is not needed in the frog, disappears. In many other cases, cell death helps regulate cell numbers. In the developing nervous system, for example, cell death adjusts the number of nerve cells to match the number of target cells that require innervation. In all these cases, the cells die by apoptosis as well[2].

[2] D.R. Williams et al. An apoptosis-inducing small molecule that binds to heat shock protein 70. Angew. Chem. Int. Ed. Engl. 2008, 47, 7466-7469.
[1] B. Alberts, A. Johnson, J. Lewis et al. Molecular Biology of the Cell. 4th edition. New York. Garland Science, 2002. 

11 Item(s)

per page
Axon ID Name Description From price
2607 YM201636 Selective inhibitor of PIKfyve (type III PtdInsP kinase) €65.00
2951 XL 388 Highly potent, selective, ATP-competitive, and orally bioavailable mTOR inhibitor €125.00
3794 Urolithin A Inhibitor of the PI3K/AKT/mTOR pathway €70.00
2525 OSU 03012 ATP-competitive PDK-1 inhibitor reducing PAK/Akt phosphorylation and cell proliferation €95.00
2029 NVP-BGT226 Orally active dual PI3K/mTOR inhibitor €120.00
3046 MRT 67307 TBK1 and IKKϵ inhibitor €125.00
3247 Miltefosine PI3K/Akt inhibitor €50.00
4149 Everolimus Selective and orally active mTOR1 inhibitor Inquire
1239 Deguelin Akt inhibitor €95.00
3598 BAY-091 hydrochloride First potent and highly selective PIP4K2A inhibitor €130.00
3778 BAY-091 First potent and highly selective PIP4K2A inhibitor €130.00

11 Item(s)

per page
Please wait...